Skip to main content

Advertisement

Open Peer Review Reports for: Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Apr 2009 Submitted Original manuscript
26 Jun 2009 Reviewed Reviewer Report - Bogdan Glinski
8 Jul 2009 Reviewed Reviewer Report - Christoph Beier
Resubmission - Version 2
Submitted Manuscript version 2
10 Sep 2009 Author responded Author comments - Pierre Robe
Resubmission - Version 3
10 Sep 2009 Submitted Manuscript version 3
29 Sep 2009 Author responded Author comments - Pierre Robe
Resubmission - Version 4
29 Sep 2009 Submitted Manuscript version 4
1 Oct 2009 Author responded Author comments - Pierre Robe
Resubmission - Version 5
1 Oct 2009 Submitted Manuscript version 5
13 Oct 2009 Author responded Author comments - Pierre Robe
Resubmission - Version 6
13 Oct 2009 Submitted Manuscript version 6
Publishing
19 Oct 2009 Editorially accepted
19 Oct 2009 Article published 10.1186/1471-2407-9-372

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement